Understanding Patient Engagement Trends in TBI Clinical Research
ConditionTBI
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
Clinical trials, specifically focused on TBI, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ability to understand and the willingness to sign a written informed consent document
Participant must be 18 years of age or older
Confirmed diagnosis of TBI
Disqualifiers
Enrolled in another research study
Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
Inability to provide written informed consent
Trial population
Patients with TBI who are actively considering enrolling in a clinical study for said condition, but have not yet completed enrollment and randomization.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of TBI patients who decide to enroll in a clinical research
Time frame
3 months2
Rate of TBI patients who remain in clinical trial to trial completion
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: